| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC2834 |
| Trial ID | NCT05105867 |
| Disease | B-Cell Non-Hodgkin's Lymphoma | B-Cell Acute Lymphoblastic Leukemia |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD19 CAR-T cells |
| Phase | Early_Phase1 |
| Recruitment status | Recruiting |
| Title | CD19 Targeted Universal Chimeric Antigen Receptor T Cells Injection for CD19+ Refractory/Relapsed B-cell Malignancies |
| Year | 2021 |
| Country | China |
| Company sponsor | 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China |
| Other ID(s) | GC011-411 |
| Cohort 1 | |||||||||||||
|
|||||||||||||